Sort
17,054 grants matching “genome editing”
Role of CXCR4 in immunoglobulin light chain recombination
$579,598Marcus R Clark · University Of Chicago · R01 · FY2022 · AI
Role of CXCR4 in immunoglobulin light chain recombination
$579,598Marcus R Clark · University Of Chicago · R01 · FY2025 · AI
Role of CXCR4 in immunoglobulin light chain recombination
$579,598Marcus R Clark · University Of Chicago · R01 · FY2023 · AI
Role of CXCR4 in immunoglobulin light chain recombination
$579,598Marcus R Clark · University Of Chicago · R01 · FY2021 · AI
Mechanisms and functions of N6-methyladenosine (m6A) in cancer
$579,461Samie R Jaffrey · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Epigenetic Programming of T Cells for Enhanced Cellular Immunotherapy
$579,428Charles A Gersbach · Duke University · R01 · FY2025 · CA
Cell Specific Gene Editing to Close Diabetic Wounds
$579,318Chandan K Sen · Indiana University Indianapolis · R01 · FY2023 · DK
Genetic analysis of mechanisms of chlamydial immune evasion
$579,107David Emmet Nelson · Indiana University Indianapolis · R56 · FY2017 · AI
Caenorhabditis Intervention Testing Program at Oregon
$579,091Patrick C. Phillips · University Of Oregon · U01 · FY2025 · AG
In situ functional genomics to understand transcriptional regulation
$579,000Neville Sanjana · New York Genome Center · DP2 · FY2022 · HG
Epigenetic Mechanisms in Diabetic Embryopathy
$578,865Claudia T. Kappen · Lsu Pennington Biomedical Research Ctr · R01 · FY2019 · HD
Chemical Genetic Approaches to Study Chromatin Complexes
$578,864Brian Liau · Harvard University · R01 · FY2023 · CA
Molecular Mechanisms of Atrial Development and Regeneration
$578,824Joshua Waxman · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL
Molecular Mechanisms of Atrial Development and Regeneration
$578,787Joshua Waxman · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
The Molecular Genetics of Hemostasis
$578,742David Ginsburg · University Of Michigan At Ann Arbor · R35 · FY2017 · HL
Tafazzin and metabolic reprogramming during cardiomyopathy
$578,683Simon J Conway · Indiana University Indianapolis · R01 · FY2021 · HL
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
$578,512Joseph C Wu · Stanford University · R01 · FY2019 · HL
The Pathogenesis of RNA Splicing Factor Retinitis Pigmentosa
$577,833Eric A Pierce · Massachusetts Eye And Ear Infirmary · R01 · FY2018 · EY
Natural Killer Cell Tolerance to Self
$577,804Wayne M. Yokoyama · Washington University · R01 · FY2025 · AI
SPP1, Oxidative Stress, and Lead Toxicity
$577,714Quan Lu · Harvard School Of Public Health · R01 · FY2022 · ES
The Genetic Basis for the Evolution of Adaptive Skin Appendage Traits in Humans
$577,704Yana G Kamberov · University Of Pennsylvania · · FY2019 · SBE
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction
$577,574Yigang Wang · University Of Cincinnati · R01 · FY2023 · HL
Altered inflammatory response associated with acquired DNMT3A mutations
$577,352Minji Byun · University Of California-Irvine · R01 · FY2025 · HL
PARP-1 as a novel target for alpha-particle therapy in high-risk Neuroblastoma
$577,080Daniel A. Pryma · University Of Pennsylvania · R01 · FY2022 · CA
The Genomic Architecture of Pregnancy Loss
$577,034Michael E Talkowski · Massachusetts General Hospital · R01 · FY2021 · HD